Laetrile B17 Forte (Amygdalin) 150 Capsules - Hydrobiont Supplement for Immune Support
$44
Product Description:
Hydrobiont's Laetrile B17 Forte, also known as Amygdalin, is a unique supplement crafted from high-quality natural ingredients. This potent formula contains Vitamin B17, which is believed to offer a wide range of health benefits.
While more research is needed to fully understand its effects, Laetrile B17 Forte is traditionally associated with:
- Immune System Support: Strengthens the immune system, increasing the body's resistance to infections and promoting faster healing of wounds and post-surgical scars.
- Cardiovascular Health: May help prevent cardiovascular diseases.
- Cellular Health: Supports healthy cellular function by regulating cell membranes and removing oxidation byproducts.
- Post-Illness Recovery: Aids in recovery and rehabilitation after illness or injury.
- Skin Health: May improve skin conditions such as psoriasis, atopic dermatitis, and eczema.
- Environmental Protection: Helps protect the body from negative environmental factors.
- Blood Sugar Regulation: May help regulate blood sugar levels.
- Blood Pressure Management: May help lower blood pressure.
- Cancer Support: Traditionally used to support the body's natural defense mechanisms and may aid in slowing tumor growth and metastasis (Disclaimer: This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor before use, especially if you have pre-existing health conditions or are taking other medications).
Hydrobiont Laetrile B17 Forte is a 150-capsule supplement designed for men and women seeking to support their overall health and well-being.
Disclaimer: The information provided here is for educational purposes only and does not constitute medical advice. It is essential to consult with a healthcare professional before using this or any other supplement, especially if you have pre-existing health conditions or are taking medications. The statements regarding Laetrile B17 Forte's potential benefits have not been evaluated by the Food and Drug Administration.